Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Dec
5
2018
New Medicare Advantage and Part D Drug Pricing Proposed Rule Mintz
Dec
4
2018
Pharmaceutical and Technology Industry Innovation Growth at Stake in Helsinn Healthcare v. Teva ArentFox Schiff LLP
Dec
4
2018
EC Amends REACH to Require Information on Nanomaterials Bergeson & Campbell, P.C.
Dec
4
2018
Clarification of OSHA Rule Regarding Drug Testing and Safety Incentive Programs Polsinelli PC
Dec
4
2018
FDA Develops Educational Module on Menu Labeling Keller and Heckman LLP
Dec
4
2018
Will Hemp-Derived CBD Be Fully Legal with Passage of the 2018 Farm Bill? Not Quite… Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
3
2018
EFSA Releases Evaluation of Cyanide Risk from Foods Keller and Heckman LLP
Nov
30
2018
7th Circuit Issues Lebamoff Opinion McDermott Will & Emery
Nov
30
2018
In re Accutane Litigation: A Victory for Pharmaceutical Companies on Choice of Law and Label Warnings Sills Cummis & Gross P.C.
Nov
30
2018
OIG Work Plan Monthly Updates (July, August, September, October 2018) von Briesen & Roper, s.c.
Nov
30
2018
FDA Finds High Levels of Heavy Metals in Kratom Products Keller and Heckman LLP
Nov
29
2018
HRSA Establishes January 1, 2019 Effective Date for 340B Ceiling Price and Civil Monetary Penalty Rule Epstein Becker & Green, P.C.
Nov
29
2018
CMS Issues Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses Sheppard, Mullin, Richter & Hampton LLP
Nov
28
2018
California’s Proposition 12 Animal Welfare Measure Wins Big – Requires Cage-Free Eggs by 2022 Keller and Heckman LLP
Nov
28
2018
November 2018 Regulatory Developments Giordano, Halleran & Ciesla, P.C.
Nov
27
2018
Missouri Goes Green: What Employers Need to Know About the State’s New Medical Marijuana Law Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Nov
27
2018
Multistate E. Coli Outbreak Linked to Romaine Lettuce Grown in California Keller and Heckman LLP
Nov
26
2018
Can I Bring Cannabis from Canada Home? Epstein Becker & Green, P.C.
Nov
26
2018
EFSA Opens Public Consultation on Draft TTC Guidance Keller and Heckman LLP
Nov
26
2018
FDA Action Against Dietary Supplements Containing Tianeptine Signals Renewed Focus on Protecting Consumers from Dietary Supplements with Unauthorized Drug Claims Keller and Heckman LLP
Nov
21
2018
FDA and CDC Investigate Multistate E. coli Outbreak Linked to Romaine Keller and Heckman LLP
Nov
21
2018
Mechanism Needed to Delist FCNs for Non-Safety Reasons, Says FDA Keller and Heckman LLP
Nov
20
2018
Blog Series Part 7: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, and Medicaid Managed Care Programs for 2020 and 2021 Sheppard, Mullin, Richter & Hampton LLP
Nov
20
2018
FDA Loosens the Reins on Informed Consent Requirements for Certain Clinical Studies Epstein Becker & Green, P.C.
Nov
20
2018
FDA Authorizes Qualified Health Claim for Oleic Acid Keller and Heckman LLP
Nov
20
2018
U.S. Canada-RCC Stakeholder Forum to include EPA-PMRA Breakout Session Bergeson & Campbell, P.C.
Nov
19
2018
Important Details Remain Unsettled Following USDA and FDA Announcement of Decision to Jointly Regulate Cell-Cultured Meat Keller and Heckman LLP
Nov
19
2018
FDA Announces Plan for Restricting Access to Flavored E-Cigarettes Stark & Stark
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins